ArticleHealth economics review2026
Beyond average costs: large-scale evidence on DRG payment reform and the distribution of standardized inpatient spending in China.
Article in Health economics review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUnder pressures of health insurance cost containment and high-quality development, diagnosis-related groups (DRGs) and other case-based payment schemes have become a major direction of China’s inpatient payment reform, yet their impacts may extend beyond changes in mean costs. Using large-scale inpatient settlement data, we evaluate the cost-containment effects of DRG payment reform from a distributional perspective, testing whether the reform is reflected not only in a decline in mean standardized inpatient spending but also in reshaping spending variability and heavy tails (tail risk).
methodsThe study covers six cities in China’s Province S from January 2019 to December 2021; three cities launched DRG reform in November 2020, January 2021, and June 2021, respectively. The individual-level sample includes 6,882,875 admissions from 172 healthcare institutions and is aggregated into a hospital–month panel; we construct individual standardized inpatient spending as “spending per admission divided by DRG weight,” and then compute the hospital–month mean, standard deviation, skewness, and kurtosis of standardized spending. Our identification strategy applies a two-stage difference-in-differences (DID) estimator suited to staggered adoption to estimate the average treatment effect, and uses the Sun & Abraham event-study approach to test parallel trends and trace dynamic effects; we control for patient composition and city-level covariates and include institution and month fixed effects; we further assess heterogeneity by hospital level and DRG design (point-based vs. rate-based).
resultsThe two-stage DID results show that DRG implementation is associated with a significant reduction in the hospital–month mean of standardized spending (β = −705.7, p < 0.001) and a significant reduction in the standard deviation (β = −1,098.0, p < 0.001); meanwhile, distributional shape metrics increase, with higher skewness (β = 0.380, p < 0.05) and higher excess kurtosis (β = 18.3, p < 0.01). In the event-study analysis, most pre-reform lead coefficients fluctuate around zero and their confidence intervals largely cover zero, providing overall support for the parallel-trends assumption. Regarding heterogeneity, relative to secondary hospitals, the interaction term for tertiary hospitals is not statistically significant across all four outcomes. Relative to the rate-based design, the point-based design shows a significant mitigating effect on distributional shape metrics, reducing skewness (β = −0.941, p < 0.001) and excess kurtosis (β = −38.4, p < 0.001), while differences in the mean and standard deviation are not statistically significant.
conclusionsWhile DRG payment reform reduces the mean level of standardized inpatient spending and within-hospital spending variability, it may be accompanied by a strengthened right tail and heavier tails, indicating that “mean-based cost containment” is insufficient to characterize the reform’s structural consequences; distributional metrics and tail risk should be incorporated into routine performance assessment and regulatory frameworks. Compared with the rate-based approach, the point-based approach appears more advantageous in curbing heavy-tail indicators, underscoring the importance of settlement mechanisms and payment-parameter design for risk discipline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.